Impact of steatosis and inflammation definitions on the performance of NASH tests.

Authors:
Poynard T; Munteanu M; Charlotte F; Perazzo H; Ngo Y and 7 more

Journal:
Eur J Gastroenterol Hepatol

Publication Year: 2018

DOI:
10.1097/MEG.0000000000001033

PMCID:
PMC5865485

PMID:
29280921

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur J Gastroenterol Hepatol

Abbreviation: Eur J Gastroenterol Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepati…
Wang X; Liu H; Wang P and 3 more (2024) - Transparency Score: 3/6
AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV i…
Lai X; Chen H; Dong X and 7 more (2024) - Transparency Score: 3/6
Construction and validation of the predictive model for gallbladder cancer liver metastasis patient…
Zhang W; Chen Z; Sa B. (2024) - Transparency Score: 3/6
Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn's dise…
D'Haens G; Baert F; Danese S and 8 more (2024) - Transparency Score: 3/6
Management advice for patients with reflux-like symptoms: an evidence-based consensus.
Hungin AP; Yadlapati R; Anastasiou F and 8 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest T.P. is the inventor of FibroTest/SteatoTest and the founder of BioPredictive, the company that markets these tests. Patents belong to the French Public Organization Assistance Publique-Hôpitaux de Paris. M.M., Y.N., O.D. are BioPredictive employees. For the remaining authors there are no conflicts of interest."

Evidence found in paper:

"The research leading to these results has received funding from the European Community’s Seventh Framework Program (FP7/2007–2013) under grant agreement no. HEALTH-F2-2009-241762 for the project FLIP."

Evidence found in paper:

"Trial registration number: USA-NCT01927133."

Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025